EP Patent
EP2617709B8 — Guanidine derivatives as antiviral agents
Assigned to Biotron Ltd · Expires 2022-12-21 · 3y expired
What this patent protects
Patent listed against Veklury.
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.